Monthly donations are beating cancer

Content not working due to cookie settings.

Manage your cookie settings here

How your monthly gift helps us beat cancer

A regular income means we can plan ahead

We can commit to long-term projects with huge potential

Spending less on fundraising means more spent on treatments

You’ll be funding the work of our scientists and helping patients

We combined treatments, so morning dog walks can continue

Thanks to our PARTNER trial, Fiona (above) can still take her dog, Murphy, out for his morning walk. Your support means we can commit to long-term research projects like this one and give people like Fiona their everyday moments back.

Fiona was diagnosed with triple negative breast cancer in 2017. This type of cancer is particularly hard to treat because it tends to grow and spread aggressively. So when Fiona discovered she was a candidate for the trial, she decided to take part, just the second person in Southampton to sign up.

"The oncologist said, ‘We are aiming to cure you.' and that stayed with me. A cancer diagnosis can be so scary, but it was a blessing I was able to get on the trial."

Thanks to our scientists, following the treatment, Fiona is now doing well.

Progress like this represents hope for us all. And thanks to your regular donation, we'll continue to find new ways to beat cancer, day in and day out.

Your regular donations power life-saving research

With your help, over the past 50 years we’ve helped to double cancer survival in the UK.

But there are still more than 385,000 new cancer cases in the UK every year, that’s more than 1,000 every day (2017-2019).

We’re determined to go further and faster to fund the research that will beat cancer. Thanks to you, we can plan ahead and commit to long-term research projects that will help people live longer, better lives, free from the fear of cancer.

We are beating cancer, together.

How we spend your money

In 2022/23, we spent £415m on new and ongoing research. This included:

£176m on research projects focused on specific cancer types.
£89m relevant to all types of cancer e.g. research equipment, facilities and studies looking at cancer survivorship.
£83m on basic research, understanding the fundamental biology of cancer (how cancers start, grow and spread).
£40m on research admin and support costs e.g. peer review, grant management and IT
£27m on revenue shares. This is the share of royalties from sales of innovations developed from our research, which we passed on to others.